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Objectives. The aim of this study was to assess the effects of clonidine on intraoperative analgesia, sedation, intraocular and
blood pressure, arrhythmia, and ischemia. Methods. Forty patients undergoing cataract surgery were allocated into two groups.
They were monitored with Holter machine, the pupil was dilated, and 30 minutes later, 20 patients received clonidine (4𝜇g/kg),
while the other 20 patients were given a 0.9% saline intravenously. Twenty minutes later, 2% lidocaine gel was applied. There
were assessed intraoperative analgesia, intraocular pressure, blood pressure, heart rate, and the occurrence of arrhythmias and
myocardial ischemia. Results. Pain intensity was lower in G1 during the phacoemulsification, irrigation, aspiration, and intraocular
lens implantation. The HR and BP were lower with clonidine. The IOP was lower with clonidine after 15 minutes and at the end of
the surgery. Sedation was higher with clonidine. The incidence of arrhythmia was lower at the end of surgery with clonidine. The
incidence of myocardial ischemia did not differ between the groups. Conclusions. Clonidine (4𝜇g/kg) before a phacoemulsification
reduced the intensity of pain during cataract surgery. It also induced sedation, reduction of BP, HR, and incidence of arrhythmia
at the end of the surgery, and did not alter myocardial ischemia. This trial is registered with Clinicaltrials.gov NCT01677351.
1. Introduction
Cataract extraction requires analgesia, ocular akinesia, and is
performed in the outpatient surgery [1].
Topical anesthesia is indicated in procedures involving
the anterior part of the eye, lasting less than two hours.
Sedation is performed so that the patients remain quiet and
do not interfere with the procedure [2].
Sedation is adjusted to allow for the patient’s cooperation
during the procedure. Clonidine is one of the drugs used
in this context because it causes sedation without inducing
hypnosis and reduces the blood pressure (BP) and heart rate
(HR) [3, 4]. The reduction of the intraocular pressure (IOP)
represents an additional advantage of clonidine because it
makes the eye surgery easier and reduces the frequency of
complications, such as expulsion of the vitreous humor when
the lens posterior capsule is broken during phacoemulsifica-
tion [5].
Following the development of phacoemulsification, top-
ical anesthesia became a well-accepted minimally invasive
technique, although it does not provide an analgesia that is
as efficacious as blocks [6].The authors of a review concluded
that clonidine promotes a reduction of postoperative pain [7].
This led us to conduct the study with the aim of assessing the
effect of clonidine on the intraoperative analgesia, sedation,
and intraocular pressure in patients subjected to cataract
extraction under topical anesthesia. The expected main out-
come was an improvement of the intraoperative analgesia.
The secondary outcomeswere better sedation and a reduction
of the intraocular pressure (IOP) and arrhythmia.
2. Materials and Methods
The study was prospective, randomized, and double-blind
and registered atClinicalTrials.gov under codeNCT01677351.
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The patients were allocated into two groups of equal
size. Random allocation to the groups was performed by
means of numbers placed inside envelopes. Before the onset
of anesthesia, a nurse or anesthetist who was not involved
in the participant’s later follow-up opened the envelope and
prepared the syringes with clonidine or 0.9% saline solution
as indicated. No other investigator who participated in the
study or data collection was aware of the group to which each
participant was allocated.
Following the approval by theResearch Ethics Committee
of Federal University of Sa˜o Paulo (number 0609/01) and sig-
nature on the informed consent form, 40 patients who were
40 to 80 years of age, of both genders, with anASA (American
Society of Anesthesia) I, II, or III physical status, and sub-
jected to cataract extraction bymeans of phacoemulsification
under topical anesthesia at a tertiary university hospital were
assessed.The followingwere excluded: patientswith coronary
heart disease, heart arrhythmias, or chronic pain; patients
using analgesics 2 weeks before surgery; patientswith tremors
or cough; patients who had previous surgery; patients with
claustrophobia, glaucoma, psychiatric disorders, or difficulty
in communicating; and pregnant patients.
Monitoring included the following: electrocardiogram
using a Holter device, arterial pressure (AP), heart rate
(HR), oxygen saturation, and placement of a venous catheter
followed by pupil dilation using 10% phenylephrine (two
drops) and 1% tropicamide (two to eight drops). Thirty
minutes later, the patients in clonidine group were given a
clonidine solution (4mcg⋅kg−1), while the patients in placebo
group were given 0.9% saline solution. Twenty minutes later,
topical anesthesia was performed with 2% lidocaine gel that
was placed on the inferior conjunctival sac, and the patient
was released for surgery.
Whenever it was needed, anesthesia was supplemented by
instillation of 2% lidocaine (three to five drops) or an intra-
cameral injection of 2% lidocaine (0.5mL). These interven-
tions were properly recorded.
Intraoperative analgesia was assessed on a numerical
scale ranging from 0 to 10, before injection of the solution,
after 5 and 15minutes, blepharostat placement, incision of the
cornea, capsulorhexis, phacoemulsification, irrigation and
aspiration, and lens implantation, and at the end of surgery.
Sedationwas assessed bymeans of the Ramsay Sedation Scale
((1) patient is anxious; (2) patient is calm and awake; (3)
patient is sleepy but opens eyes on command; (4) patient is
sleeping and only responds to vigorous verbal stimuli; (5)
patient is sleeping and responds to pain stimulation by glabel-
lar tap; (6) patient does not respond to pain stimuli).The IOP
was measured before and 15 minutes after administration of
the solutions to both eyes and after the surgical procedure
in only the eye not subjected to the surgery. The continuous
electrocardiogram, Holter series 8500, was applied after the
pupil dilation and was discontinued immediately at the end
of surgery. The traces were analyzed by a cardiologist. Alter-
ations of the ST segment and arrhythmias were analyzed.
The Instat Graph statistical software was used for the
sample calculations and analysis of the results. A difference
of 30% in pain intensity according to a numerical scale was
Table 1: Demographic data.
Clonidine (𝑛 = 20) Placebo (𝑛 = 20) 𝑃
Age (years) 64.3 (8.2) 65.5 (10.7) 0.69
Weight (kg) 65.8 (10.7) 70.0 (13.1) 0.28
Height (cm) 162.1 (8.5) 162.5 (8.8) 0.89
Gender (M : F) 7 : 13 9 : 11 0.75
Student’s 𝑡-test.
Table 2: Intensity of pain, mean (SD).
Time points Clonidine(𝑛 = 20)
Placebo
(𝑛 = 20) 𝑃
Control 0.4 (1.0) 0.2 (0.7) 0.77
5min 0.3 (0.9) 0.2 (0.7) 0.79
15min 0.3 (0.9) 0.2 (0.7) 0.79
Blepharostat 0.3 (0.9) 0.2 (0.7) 0.79
Incision of the cornea 0.3 (0.9) 0.2 (0.5) 0.99
Capsulorhexis 0.5 (1.1) 0.9 (1.3) 0.43
Phacoemulsification 1.4 (1.6) 3.9 (3.2) 0.02
Irrigation-aspiration 1.4 (2.0) 3.1 (2.7) 0.04
Lens implantation 1.7 (2.0) 3.6 (2.4) 0.01
End 1.1 (1.7) 1.8 (1.8) 0.20
Mann-Whitney test.
considered clinically significant for 80% power and a 95%
confidence interval (95% CI). Based on a preliminary eval-
uation, a standard deviation (SD) of 2.2 was estimated for
the pain intensity score within the group of patients; the
calculated sample size was 20 patients per group [8]. The
statistical tests used were as follows: Student’s 𝑡-test for age,
body weight, height, IOP, HR, AP, and length of surgery and
the Mann-Whitney test for HR, AP, pain intensity, sedation,
IOP, and arrhythmia. Measures of central tendency, mean,
and dispersion (standard deviation) were used. The level of
statistical significance was established as <0.05.
3. Results
The study sequence is described in a CONSORT diagram
(Figure 1).
There was no difference between the groups regarding the
demographic data (Table 1).Thephysical statuswas class ASA
I for six patients in clonidine and eight patients in placebo
group, and it was ASA II for eight patients in clonidine and 12
patients in placebo, without a significant difference between
the groups (𝑃 = 0.7411; Mann-Whitney test). The surgery
lasted 22 ± 9.9min for clonidine and 24 ± 12min for placebo
(𝑃 = 0.05692; Student’s 𝑡-test).
The intensity of pain exhibited a significant difference
between the groups at the assessed time points (Table 2).
Sedation was greater in G1 at almost all the assessed time
points (𝑃 < 0.05; Mann-Whitney test) (Table 3). Sedation
increased in G1 between the onset (2.0 ± 0.0) and end (2.5
± 0.6) of the surgery, which did not occur in G2 (2.0 ± 0.0
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Enrollment
Allocation
Follow-up
Analysis
Assessed for eligibility (N = 100)
Excluded (N = 60)
∙ Not meeting inclusion criteria (N = 60)
∙ Refused to participate (N = 0)
Randomised (N = 40)
Allocated to clonidine group (N = 20)
∙ Submitted to clonidine (N = 20)
∙ Did not submit to clonidine (N = 0)
Allocated to placebo group (N = 20)
∙ Submitted to placebo (N = 20)
∙ Did not submit to placebo (N = 0)
Lost to follow-up (N = 0)
Discontinued (N = 0)
Analyzed (N = 20)
Excluded from analysis (N = 0)
Lost to follow-up (N = 0)
Discontinued (N = 0)
Analyzed (N = 20)
Excluded from analysis (N = 0)
Figure 1: CONSORT flowchart.
Table 3: Sedation (Ramsay Scale), mean (SD).
Time points Clonidine(𝑛 = 20)
Placebo
(𝑛 = 20) 𝑃
Incision of the cornea 3.0 (0.5) 2.1 (0.3) 0.001
Irrigation-aspiration 2.8 (0.6) 1.9 (0.2) 0.001
Lens implantation 2.7 (0.6) 1.9 (0.2) 0.001
Mann-Whitney test.
and 2.0± 0.0, respectively; Kruskal-Wallis analysis of variance
(ANOVA test)).
The HR was lower when clonidine was used. The greatest
HRmeasured was 69.4±8.6 in G1 and 76.0±18.5 in G2, while
the lowest HR was 63.2 ± 11.1 in G1 and 69.3 ± 17.9 in G2.
At some time points, the systolic arterial pressure (SAP)
was lower when clonidine was used (𝑃 < 0.05; Mann-
Whitney test). At some time points, the diastolic arterial
pressure (DAP) was lower when clonidine was used.
The IOP of the nonmydriatic eye exhibited a significant
difference between the groups 15 minutes after injection of
the solution (clonidine = 12.9 ± 3.1 and placebo = 15.5 ± 3.2;
𝑃 = 0.0135; Mann-Whitney test) and at the end of surgery
(clonidine = 12.5 ± 3.4 and placebo = 15.3 ± 2.7; 𝑃 = 0.0065;
Mann-Whitney test). The IOP of the mydriatic eye did not
exhibit a difference between the groups.
The incidence of arrhythmia was higher in placebo only
at the end of surgery, and there was no difference in the
incidence of myocardial ischemia (Table 4).
4. Discussion
Clonidine promoted a reduction in the intensity of intraop-
erative pain. It also promoted sedation and was associated
with reductions in the BP, HR, and IOP. It did not reduce the
incidence of arrhythmias or myocardial ischemia.
The intensity of pain decreased during the surgical
steps that are considered to be uncomfortable. Although
supplementary analgesia was not required in either group,
the intensity of pain was lower when clonidine was used,
thus showing that this drug is appropriate for the intended
procedure.
In spite of its disadvantages,many patients prefer a topical
anesthesia to a block due to the greater discomfort caused by
the use of needles [6]. The analgesic effect is not as good as
after blocks but there are fewer complications [6].
Complementary analgesia might be achieved with intra-
cameral 1% lidocaine, which is effective as a supplement to
topical anesthesia in cataract surgery via phacoemulsification
[9]. In the present study, complementation was not required.
The safety of sedatives is related to the incidence of com-
plications. The sedative and anxiolytic effects of clonidine,
which are mediated through its binding to alpha-2 receptors
[8], might avoid complications related to sympathetic stimu-
lation [2]. In this study, no patients required supplementary
sedation. In spite of the sedation induced by clonidine, the
patients who received it were as awake at the end of surgery as
the ones who were given a placebo, although the length of the
procedure was shorter. For this reason, the time to hospital
discharge did not differ.
Reduced IOP during cataract extraction facilitates the
surgery performance and reduces the risk of complications.
In the present study, the IOP of the patients given clonidine
decreased at the end of the surgery (approximately 30min),
which was similar to another study [4].
Clonidine might reduce the HR and BP mediated by
a decreased release of peripheral norepinephrine and a
central sympatholytic effect [10]. In the present study, the HR
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Table 4: Incidence of arrhythmia and myocardial ischemia (percentage).
Arrhythmia Ischemia
Clonidine (𝑛 = 20) Placebo (𝑛 = 20) 𝑃 Clonidine (𝑛 = 20) Placebo (𝑛 = 20) 𝑃
Control 7 (46.6%) 6 (37.5%) 0.7224 2 (13.3%) 0 (0%) 0.23
5min 3 (20%) 3 (18.7) 1.0000 0 (0%) 0 (0%) NSA
15min 2 (13.3%) 5 (31.3) 0.40 1 (6.6%) 0 (0%) 0.48
Blepharostat 4 (26.7%) 5 (31.3) 1.00 0 (0%) 0 (0%) NSA
Incision of the cornea 0 (0%) 4 (25%) 0.10 0 (0%) 0 (0%) NSA
Capsulorhexis 1 (6.6%) 4 (25%) 0.33 0 (0%) 0 (0%) NSA
Phacoemulsification 4 (26.7%) 6 (37.5%) 0.70 0 (0%) 3 (18.7%) 0.23
Irrigation-aspiration 3 (20%) 5 (31.3) 0.69 0 (0%) 3 (18.7%) 0.23
Lens implantation 2 (13.3%) 6 (37.5%) 0.22 0 (0%) 3 (18.7%) 0.23
End 0 (0%) 5 (31.3) 0.04 0 (0%) 0 (0%) NSA
NSA: not submitted to analysis; Fisher’s exact test.
was lower when clonidine was used; however, it remained
within the normal range. There are no reports on significant
alterations of the AP or HR when these mydriatics are used
at their usual doses [8]. Bradycardia is a rare complication
of clonidine even when used at high doses. The BP was lower
when clonidine was used, but neither hyper- nor hypotension
occurred with the dose used in the present study. Clonidine
reduces the BPmainlywhen large doses are used. Bradycardia
and hypotension were reported with higher doses (300mcg)
[7].
Clonidine might also reduce the incidence of myocardial
ischemia in patients with coronary heart disease [11–13].
In the present study, the incidence of arrhythmia exhibited
a difference only at the end of surgery, which suggests
the antiarrhythmic action of clonidine. Arrhythmia before
anesthesia might be related to the use of mydriatics and
to anxiety. By inhibiting the sympathetic activity, clonidine
might act as an anxiolytic and antiarrhythmogenic agent
[14, 15].
The results of the present study suggest that clonidine at a
dose of 4 𝜇/kg via an intravenous route promotes an analgesic
effect and sedation appropriate for cataract extraction by
means of phacoemulsification under topical anesthesia with-
out altering the heart rate or the systemic arterial pressure.
The results of the recent study further suggest that the use of
clonidine reduces the incidence of arrhythmia.
Limitations
Although no cardiovascular adverse effects were observed,
the sample size of this study is too small tomake any clinically
relevant conclusions. In fact, the cataract population is
usually old, has several comorbidities, and thus is at a very
high risk of cardiovascular complications.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Authors’ Contribution
AnaEQSantiago contributed to study conception and design,
data collection, and paper writing. Adriana M Issy con-
tributed to data analysis and interpretation. Rioko K Sakata
contributed to study conception and design, paper writing,
critical revision of the intellectual content, and final version
approval.
Funding
Departmental, hospital-based, institutional funding is ac-
knowledged.
References
[1] P. R. Rothchild, S. Grabar, and B. le Du, “Patients subjective as-
sessment of the duration of cataract surgery: a case series,” BMJ
Open, vol. 3, no. 5, Article ID e002497, 2013.
[2] R. Dogan, A. Karalezli, D. Sahin, and F. Gumus, “Comparison
of sedative drugs under peribulbar or topical anesthesia during
phacoemulsification,” Ophthalmic Surgery Lasers and Imaging,
vol. 43, no. 2, pp. 121–127, 2012.
[3] C. E. Schneemilch, H. Bachmann, A. Ulrich, R. Elwert, Z. Hal-
loul, and T. Hachenberg, “Clonidine decreases stress response
in patients undergoing carotid endarterectomy under regional
anesthesia: a prospective, randomized, double-blinded, pla-
cebo-controlled study,” Anesthesia and Analgesia, vol. 103, no.
2, pp. 297–302, 2006.
[4] M. A. Vann, B. O. Ogunnaike, and G. P. Joshi, “Sedation and
anesthesia care for ophthalmologic surgery during local/region-
al anesthesia,” Anesthesiology, vol. 107, no. 3, pp. 502–508, 2007.
[5] G.Weigert, H. Resch, A. Luksch et al., “Intravenous administra-
tion of clonidine reduces intraocular pressure and alters ocular
blood flow,” British Journal of Ophthalmology, vol. 91, no. 10, pp.
1354–1358, 2007.
[6] L. Q. Zhao, H. Zhu, P. Q. Zhao, Q. R.Wu, and Y. Q. Hu, “Topical
anesthesia versus regional anesthesia for cataract surgery: a
meta-analysis of randomized controlled trials,”Ophthalmology,
vol. 119, pp. 659–667, 2012.
[7] G. Blaudszun, C. Lysakowski, N. Elia, andM. R. Trame`r, “Effect
of perioperative systemic 𝛼2 agonists on postoperative mor-
phine consumption and pain intensity: systematic review and
Journal of Ophthalmology 5
meta-analysis of randomized controlled trials,” Anesthesiology,
vol. 116, no. 6, pp. 1312–1322, 2012.
[8] J. E. Hall, T. D. Uhrich, and T. J. Ebert, “Sedative, analgesic
and cognitive effects of clonidine infusions in humans,” British
Journal of Anaesthesia, vol. 86, no. 1, pp. 5–11, 2001.
[9] D. G. Ezra and B. D. Allan, “Topical anaesthesia alone versus
topical anaesthesia with intracameral lidocaine for phacoemul-
sification,” Cochrane Database of Systematic Reviews, vol. 18, no.
3, Article ID CD005276, 2007.
[10] D. L. Greehalgh andC.M. Kumar, “Sedation during ophthalmic
surgery,” European Journal of Anaesthesiology, vol. 25, pp. 701–
707, 2008.
[11] E. Farag, M. Argalious, D. I. Sessler, A. Kurz, Z. Y. Ebrahim,
and A. Schubert, “Use of 𝛼2-agonists in neuroanesthesia: an
overview,” Ochsner Journal, vol. 11, no. 1, pp. 57–69, 2011.
[12] M. M. S. Motta, J. Coblentz, B. F. Fernandes, and M. N. Burnier
Jr., “Mydriatic and cardiovascular effects of phenylephrine 2.5%
versus phenylephrine 10%, both associated with tropicamide
1%,” Ophthalmic Research, vol. 42, no. 2, pp. 87–89, 2009.
[13] D.N.Wijeysundera, J. S.Naik, andW. S. Beattie, “𝛼-2 adrenergic
agonists to prevent perioperative cardiovascular complications:
a meta-analysis,”TheAmerican Journal of Medicine, vol. 114, no.
9, pp. 742–752, 2003.
[14] R. Aantaa and J. Jalonen, “Perioperative use of 𝛼2-adrenoceptor
agonists and the cardiac patient,” European Journal of Anaesthe-
siology, vol. 23, no. 5, pp. 361–372, 2006.
[15] S. A. Chalikonda, “𝛼2-adrenergic agonists and their role in the
prevention of perioperative adverse cardiac events,” Journal of
the American Association of Nurse Anesthetists, vol. 77, no. 2, pp.
103–108, 2009.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
